These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9550644)

  • 1. Bone alkaline phosphatase in children with chronic renal failure.
    Behnke B; Kemper M; Kruse HP; Müller-Wiefel DE
    Nephrol Dial Transplant; 1998 Mar; 13(3):662-7. PubMed ID: 9550644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
    Ureña P; Hruby M; Ferreira A; Ang KS; de Vernejoul MC
    J Am Soc Nephrol; 1996 Mar; 7(3):506-12. PubMed ID: 8704118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of total alkaline phosphatase and three assays for bone-specific alkaline phosphatase in childhood and adolescence.
    Rauch F; Middelmann B; Cagnoli M; Keller KM; Schönau E
    Acta Paediatr; 1997 Jun; 86(6):583-7. PubMed ID: 9202791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
    Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA
    Nephron; 1997; 75(4):412-9. PubMed ID: 9127327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms.
    Magnusson P; Sharp CA; Magnusson M; Risteli J; Davie MW; Larsson L
    Kidney Int; 2001 Jul; 60(1):257-65. PubMed ID: 11422759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
    Ziółkowska H; Roszkowska-Blaim M
    Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
    Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
    Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical assessment of the relationship between bone scintigraphy and serum biochemical markers in hemodialysis patients.
    Kurata S; Ishibashi M; Nishida H; Hiromatsu Y; Hayabuchi N
    Ann Nucl Med; 2004 Sep; 18(6):513-8. PubMed ID: 15515752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of alkaline phosphatase isoenzymes, bone histology, and skeletal radiography in dialysis bone disease.
    Naik RB; Gosling P; Price CP
    Br Med J; 1977 May; 1(6072):1307-10. PubMed ID: 861592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of bone in the diagnostics of renal osteodystrophy in children with chronic renal failure.
    Ziółkowska H; Pańczyk-Tomaszewska M; Majkowska Z; Rajkowski T; Debiński A; Przedlacki J; Sawicki A; Ostrowski K; Marciński A; Roszkowska-Blaim M
    Med Sci Monit; 2001; 7(5):1034-42. PubMed ID: 11535955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.
    Doyon A; Fischer DC; Bayazit AK; Canpolat N; Duzova A; Sözeri B; Bacchetta J; Balat A; Büscher A; Candan C; Cakar N; Donmez O; Dusek J; Heckel M; Klaus G; Mir S; Özcelik G; Sever L; Shroff R; Vidal E; Wühl E; Gondan M; Melk A; Querfeld U; Haffner D; Schaefer F;
    PLoS One; 2015; 10(2):e0113482. PubMed ID: 25659076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interest of bone alkaline phosphatase in hemodialysis patients].
    Helal I; Bahlous A; El Younsi F; Ben Hamida F; Abdelmoula J; Belkahia C; Kheder A
    Tunis Med; 2008 May; 86(5):427-30. PubMed ID: 19469294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone alkaline phosphatase isoenzyme in renal osteodystrophy.
    Jarava C; Armas JR; Salgueira M; Palma A
    Nephrol Dial Transplant; 1996; 11 Suppl 3():43-6. PubMed ID: 8840311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.
    Kobayashi I; Shidara K; Okuno S; Yamada S; Imanishi Y; Mori K; Ishimura E; Shoji S; Yamakawa T; Inaba M
    Life Sci; 2012 Jan; 90(5-6):212-8. PubMed ID: 22154904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
    Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of parathyroidectomy on bone remodeling markers and vitamin D status in patients with chronic kidney disease-mineral and bone disorder.
    Peters BS; Moyses RM; Jorgetti V; Martini LA
    Int Urol Nephrol; 2007; 39(4):1251-6. PubMed ID: 17680337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure].
    Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M
    Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone alkaline phosphatase besides intact parathyroid hormone in hemodialysis patients--any advantage?
    Jorge C; Gil C; Possante M; Silva E; Andrade R; Santos N; Cruz A; Teixeira R; Ferreira A
    Nephron Clin Pract; 2005; 101(3):c122-7. PubMed ID: 16015001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases.
    Woitge HW; Seibel MJ; Ziegler R
    Clin Chem; 1996 Nov; 42(11):1796-804. PubMed ID: 8906079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase.
    Fischer DC; Mischek A; Wolf S; Rahn A; Salweski B; Kundt G; Haffner D
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):546-53. PubMed ID: 22984195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.